Liminatus Pharma Inc. (LIMN)
LIMN trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.41
-1.16% on the day
Market cap
$4.6M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | LIMN on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001971387 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1 | 2026-06-24 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report FORM 8-K | 8-K | 2026-09-29 |
| Latest proxy | DEF 14A | 2026-07-13 |
Source: SEC EDGAR submissions feed, 108 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PMCB | PharmaCyte Biotech Inc. | $0.3559 | -2.52% | $3.8M |
| BTTC | Black Titan Corporation | $0.4380 | -10.70% | $6.0M |
| CELZ | Creative Medical Technology Holdings Inc. | $0.8199 | -2.51% | $6.2M |
| CLDI | Calidi Biotherapeutics Inc. | $0.8999 | -5.26% | $3.3M |
| AIM | AIM ImmunoTech Inc. | $0.1699 | -4.23% | $6.8M |
| VIVS | VivoSim Labs Inc. | $0.1742 | +0.12% | $2.9M |
| SNTI | Senti Biosciences Holdings Inc. | $0.2550 | -19.96% | $7.9M |
| SLXN | Silexion Therapeutics Corp | $0.1760 | -1.24% | $2.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier